These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36062292)

  • 1. Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis.
    Chen H; Zhao W; Yan X; Huang T; Yang A
    J Clin Transl Hepatol; 2022 Aug; 10(4):577-588. PubMed ID: 36062292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice.
    Rao A; van de Peppel IP; Gumber S; Karpen SJ; Dawson PA
    Front Med (Lausanne); 2020; 7():60. PubMed ID: 32158763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice.
    Yang A; Yan X; Fan X; Shi Y; Huang T; Li W; Chen W; Jia J; You H
    Hepatol Int; 2021 Oct; 15(5):1122-1135. PubMed ID: 34014450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
    Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice.
    Yang L; Miura K; Zhang B; Matsushita H; Yang YM; Liang S; Song J; Roh YS; Seki E
    Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):469-483. PubMed ID: 28462384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.
    Nakanishi K; Kaji K; Kitade M; Kubo T; Furukawa M; Saikawa S; Shimozato N; Sato S; Seki K; Kawaratani H; Moriya K; Namisaki T; Yoshiji H
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet.
    Ibusuki R; Uto H; Arima S; Mawatari S; Setoguchi Y; Iwashita Y; Hashimoto S; Maeda T; Tanoue S; Kanmura S; Oketani M; Ido A; Tsubouchi H
    Liver Int; 2013 Nov; 33(10):1549-56. PubMed ID: 23682724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRP3 inflammasome activation is required for fibrosis development in NAFLD.
    Wree A; McGeough MD; Peña CA; Schlattjan M; Li H; Inzaugarat ME; Messer K; Canbay A; Hoffman HM; Feldstein AE
    J Mol Med (Berl); 2014 Oct; 92(10):1069-82. PubMed ID: 24861026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.
    Suzuki-Kemuriyama N; Abe A; Uno K; Ogawa S; Watanabe A; Sano R; Yuki M; Miyajima K; Nakae D
    Lipids Health Dis; 2020 Dec; 19(1):251. PubMed ID: 33317575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary iron restriction leads to a reduction in hepatic fibrosis in a rat model of non-alcoholic steatohepatitis.
    Abe N; Tsuchida T; Yasuda SI; Oka K
    Biol Open; 2019 May; 8(5):. PubMed ID: 31097447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.
    Yang YM; Wang Z; Matsuda M; Seki E
    Arch Pharm Res; 2021 Feb; 44(2):230-240. PubMed ID: 33486695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of nardilysin prevents the development of steatohepatitis and liver fibrotic changes.
    Ishizu-Higashi S; Seno H; Nishi E; Matsumoto Y; Ikuta K; Tsuda M; Kimura Y; Takada Y; Kimura Y; Nakanishi Y; Kanda K; Komekado H; Chiba T
    PLoS One; 2014; 9(5):e98017. PubMed ID: 24849253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis.
    Yang YM; Fukui M; Wang Z; Miao F; Karriker MJ; Seki E
    Front Endocrinol (Lausanne); 2018; 9():378. PubMed ID: 30083132
    [No Abstract]   [Full Text] [Related]  

  • 16. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent fibrosis in the liver of choline-deficient and iron-supplemented L-amino acid-defined diet-induced nonalcoholic steatohepatitis rat due to continuing oxidative stress after choline supplementation.
    Takeuchi-Yorimoto A; Noto T; Yamada A; Miyamae Y; Oishi Y; Matsumoto M
    Toxicol Appl Pharmacol; 2013 May; 268(3):264-77. PubMed ID: 23481610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice.
    Yang L; Roh YS; Song J; Zhang B; Liu C; Loomba R; Seki E
    Hepatology; 2014 Feb; 59(2):483-95. PubMed ID: 23996730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage.
    Segal-Salto M; Barashi N; Katav A; Edelshtein V; Aharon A; Hashmueli S; George J; Maor Y; Pinzani M; Haberman D; Hall A; Friedman S; Mor A
    JHEP Rep; 2020 Feb; 2(1):100064. PubMed ID: 32039405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.